Investor Relations TRANSFORMING THE WAY THE WORLD SEES THE GENOME CORPORATE PROFILE Bionano Genomics, Inc. (NASDAQ: BNGO) seeks to enhance shareholder value not only through exceptional business performance and practices, but also through responsible and effective communication with its shareholders. The latest company information relevant to the individual and institutional investor includes stock price and history, upcoming events and presentations and financial documents. STOCK INFORMATION NASDAQ CM: BNGO $3.71 +0.01 (+0.27%) Data Provided by Refinitiv. Minimum 15 minutes delayed. CORPORATE GOVERNANCE Erik Holmlin, PhD PRESIDENT AND CHIEF EXECUTIVE OFFICER Christopher Stewart CHIEF FINANCIAL OFFICER Mark Oldakowski CHIEF OPERATING OFFICER Richard Shippy CHIEF BUSINESS OFFICER Jason Priar CHIEF COMMERCIAL OFFICER Alka Chaubey, PhD, FACMG CHIEF MEDICAL OFFICER Soheil Shams CHIEF INFORMATICS OFFICER View All UPCOMING AND RECENT EVENTS Nov 16 - Nov 19, 2021 AMP 2021 Nov 4, 2021 at 4:30 PM EDT 2021 BIONANO THIRD QUARTER FINANCIAL RESULTS CALL Oct 12, 2021 at 8:30 AM EDT BIONANO GENOMICS, INC. INVESTOR CALL Aug 4, 2021 from 4:30 PM to 5:30 PM EDT 2021 BIONANO SECOND QUARTER FINANCIAL RESULTS CALL View All Events FEATURED REPORTS 2020 Annual Report Mar 23, 2021 2019 Annual Report Mar 10, 2020 2018 Annual Report Mar 14, 2019 View All Reports NEWS RELEASES 29 Nov '21 BIONANO GENOMICS APPOINTS DR. KEITH GLIGORICH, SEASONED LEADER IN CLIA-CERTIFIED CAP-ACCREDITED LAB OPERATIONS, AS VP OPERATIONS FOR BIONANO LABORATORIES 22 Nov '21 BIONANO GENOMICS ANNOUNCES PEER-REVIEWED PUBLICATION FROM JOHNS HOPKINS UNIVERSITY OUTLINING A STEPWISE APPROACH TO THE ADOPTION OF OPTICAL GENOME MAPPING FOR CANCER ANALYSIS 15 Nov '21 BIONANO GENOMICS ANNOUNCES EXTENSIVE LINEUP OF CONTENT TO BE PRESENTED AT THE ANNUAL MEETING OF THE ASSOCIATION FOR MOLECULAR PATHOLOGY FEATURING OPTICAL GENOME MAPPING ACROSS A BROAD RANGE OF CLINICAL RESEARCH APPLICATIONS 04 Nov '21 BIONANO GENOMICS REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS AND HIGHLIGHTS RECENT BUSINESS PROGRESS View All Releases STOCK INFORMATION INFORMATION REQUEST FINANCIALS & FILINGS INVESTOR CONTACT PRINT PAGE EMAIL ALERTS RSS FEEDS REQUEST EMAIL ALERTS © 2021 Bionano Genomics, Inc. All rights reserved. For Research Use Only. Not For Use In Diagnostic Procedures. | Legal Notice | Privacy Policy